Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

ACETAMINOPHEN

ACETAMINOPHEN

Standard Dose
1GM/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ACETAMINOPHEN is listed in Drugs@FDA under application 206610 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN Form and strength POWDER;INTRAVENOUS - 1GM/VIAL Sponsor RISING Submission history Latest submission status date: 2021-01-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ACETAMINOPHEN is listed in Drugs@FDA under application 206610 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN Form and strength POWDER;INTRAVENOUS - 1GM/VIAL Sponsor RISING Submission history Latest submission status date: 2021-01-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.